Table 5.
In vitro antimalarial activities of cyclopropyl carboxamides against selected resistant clones
Compound | IC50 (μM)a for P. falciparum: |
||||
---|---|---|---|---|---|
3D7Ab | Clone E2 | Clone E3 | Clone C3 | Clone C7 | |
GSK1057714A | 0.047 | >5 | >5 | >5 | 1.640 |
GSK2645947A | 0.002 | 0.385 | 0.436 | 0.369 | 0.147 |
GSK2611622A | 0.020 | 2.241 | 2.366 | 2.486 | 1.236 |
GSK2661685A | 0.052 | >5 | >5 | >5 | 2.766 |
GSK2678892A | 0.146 | 4.862 | ND | ND | 4.533 |
Atovaquone | 0.003 | 0.005 | 0.004 | 0.005 | 0.004 |
Artemisinin | 0.027 | 0.026 | 0.024 | 0.027 | 0.022 |
Chloroquine | 0.027 | 0.031 | 0.031 | 0.033 | 0.029 |
Pyrimethamine | 0.072 | 0.050 | 0.058 | 0.055 | 0.037 |
Results are the means of three independent experiments.
Wild type.